TY - JOUR
T1 - COVID-19 in German Competitive Sports
T2 - Protocol for a Prospective Multicenter Cohort Study (CoSmo-S)
AU - Niess, Andreas Michael
AU - Widmann, Manuel
AU - Gaidai, Roman
AU - Gölz, Christian
AU - Schubert, Isabel
AU - Castillo, Katty
AU - Sachs, Jan Philipp
AU - Bizjak, Daniel
AU - Vollrath, Shirin
AU - Wimbauer, Fritz
AU - Vogel, Azin
AU - Keller, Karsten
AU - Burgstahler, Christof
AU - Quermann, Anne
AU - Kerling, Arno
AU - Schneider, Gerald
AU - Zacher, Jonas
AU - Diebold, Katharina
AU - Grummt, Maximilian
AU - Beckendorf, Claudia
AU - Buitenhuis, Johannes
AU - Egger, Florian
AU - Venhorst, Andreas
AU - Morath, Oliver
AU - Barsch, Friedrich
AU - Mellwig, Klaus-Peter
AU - Oesterschlink, Julian
AU - Wüstenfeld, Jan
AU - Predel, Hans-Georg
AU - Deibert, Peter
AU - Friedmann-Bette, Birgit
AU - Mayer, Frank
AU - Hirschmüller, Anja
AU - Halle, Martin
AU - Steinacker, Jürgen Michael
AU - Wolfarth, Bernd
AU - Meyer, Tim
AU - Böttinger, Erwin
AU - Flechtner-Mors, Marion
AU - Bloch, Wilhelm
AU - Haller, Bernhard
AU - Roecker, Kai
AU - Reinsberger, Claus
N1 - Copyright © 2022 Niess, Widmann, Gaidai, Gölz, Schubert, Castillo, Sachs, Bizjak, Vollrath, Wimbauer, Vogel, Keller, Burgstahler, Quermann, Kerling, Schneider, Zacher, Diebold, Grummt, Beckendorf, Buitenhuis, Egger, Venhorst, Morath, Barsch, Mellwig, Oesterschlink, Wüstenfeld, Predel, Deibert, Friedmann-Bette, Mayer, Hirschmüller, Halle, Steinacker, Wolfarth, Meyer, Böttinger, Flechtner-Mors, Bloch, Haller, Roecker and Reinsberger.
PY - 2022
Y1 - 2022
N2 - Objective: It is unclear whether and to what extent COVID-19 infection poses health risks and a chronic impairment of performance in athletes. Identification of individual health risk is an important decision-making basis for managing the pandemic risk of infection with SARS-CoV-2 in sports and return to play (RTP). Methods: This study aims 1) to analyze the longitudinal rate of seroprevalence of SARS-CoV-2 in German athletes, 2) to assess health-related consequences in athletes infected with SARS-CoV-2, and 3) to reveal effects of the COVID-19 pandemic in general and of a cleared SARS-CoV-2 infection on exercise performance. CoSmo-S is a prospective observational multicenter study establishing two cohorts: 1) athletes diagnosed positive for COVID-19 (cohort 1) and 2) federal squad athletes who perform their annual sports medical preparticipation screening (cohort 2). Comprehensive diagnostics including physical examination, laboratory blood analyses and blood biobanking, resting and exercise electrocardiogram (ECG), echocardiography, spirometry and exercise testing added by questionnaires are conducted at baseline and follow-up. Results and Conclusion: We expect that the results obtained, will allow us to formulate recommendations regarding RTP on a more evidence-based level.
AB - Objective: It is unclear whether and to what extent COVID-19 infection poses health risks and a chronic impairment of performance in athletes. Identification of individual health risk is an important decision-making basis for managing the pandemic risk of infection with SARS-CoV-2 in sports and return to play (RTP). Methods: This study aims 1) to analyze the longitudinal rate of seroprevalence of SARS-CoV-2 in German athletes, 2) to assess health-related consequences in athletes infected with SARS-CoV-2, and 3) to reveal effects of the COVID-19 pandemic in general and of a cleared SARS-CoV-2 infection on exercise performance. CoSmo-S is a prospective observational multicenter study establishing two cohorts: 1) athletes diagnosed positive for COVID-19 (cohort 1) and 2) federal squad athletes who perform their annual sports medical preparticipation screening (cohort 2). Comprehensive diagnostics including physical examination, laboratory blood analyses and blood biobanking, resting and exercise electrocardiogram (ECG), echocardiography, spirometry and exercise testing added by questionnaires are conducted at baseline and follow-up. Results and Conclusion: We expect that the results obtained, will allow us to formulate recommendations regarding RTP on a more evidence-based level.
KW - Biological Specimen Banks
KW - COVID-19
KW - Cohort Studies
KW - Humans
KW - Multicenter Studies as Topic
KW - Observational Studies as Topic
KW - Pandemics
KW - Prospective Studies
KW - SARS-CoV-2
KW - Seroepidemiologic Studies
U2 - 10.3389/ijph.2022.1604414
DO - 10.3389/ijph.2022.1604414
M3 - Journal articles
C2 - 35197815
SN - 1661-8556
VL - 67
SP - 1604414
JO - International Journal of Public Health
JF - International Journal of Public Health
ER -
